SCHEMBL6354092

SCHEMBL6354092

Cc1ccc(C(=O)c2ccccc2N)cc1C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.68
MAPT P10636 6/20 0.59
GAA P10253 1/20 0.59
NPC1 O15118 3/20 0.58
POLB P06746 2/20 0.58
MITF O75030 1/20 0.58
LMNA P02545 1/20 0.58
MAPK13 O15264 3/20 0.57
MAPK12 P53778 3/20 0.57
MAPK11 Q15759 3/20 0.57
MAPK14 Q16539 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.51
HTT P42858 2/20 0.51
CES2 O00748 1/20 0.51
CES1 P23141 1/20 0.51
HPGD P15428 2/20 0.51
CASP3 P42574 1/20 0.51
RAB9A P51151 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12792043 0.84 ALDH1A1 (0.74) ALDH1A1MAPTNPC1POLBMITF
SCHEMBL8374908 0.81 MAPT (0.87) ALDH1A1MAPTGAANPC1POLB
SCHEMBL16313232 0.81 ALDH1A1 (0.70) ALDH1A1MAPTNPC1POLBMITF
SCHEMBL1786654 0.81 ALDH1A1 (1.00) ALDH1A1POLBLMNASMN1; SMN2HTT
SCHEMBL31333081 0.81 ALDH1A1 (1.00) ALDH1A1POLBLMNASMN1; SMN2HTT
SCHEMBL8522631 0.80 MAPT (0.66) ALDH1A1MAPTGAANPC1POLB
SCHEMBL4639277 0.80 MAPT (0.71) ALDH1A1MAPTGAANPC1LMNA
SCHEMBL8374909 0.80 MAPT (0.77) ALDH1A1MAPTGAAPOLBLMNA
SCHEMBL15197083 0.79 ALDH1A1 (0.68) ALDH1A1MAPTGAANPC1POLB
SCHEMBL6651159 0.79 MAPK13 (0.65) ALDH1A1MAPTGAANPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6960611-B2 Sulfonyl-containing 2,3-diarylindole compounds, methods for making same, and methods of use thereof INSTITUTE OF MATERIA MEDICA (CN) 2005-11-01 US disclosed
US-20040058977-A1 Sulfonyl-containing 2,3-diarylindole compounds, methods for making same, and methods of use thereof INSTITUTE OF MATERIA MEDIC, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058977-A1 Sulfonyl-containing 2,3-diarylindole compounds, methods for making same, and methods of use thereof PTGS2, PTGES2, PTGER2 ALDH1A1 667/4885MAPT 4789/4885GAA 1977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.